Hudson Bay Capital Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.7M | Buy |
225,000
+45,000
| +25% | +$373K | 0.01% | 741 |
|
|
2026
Q1 | $1.51M | Buy |
180,000
+40,000
| +29% | +$420K | 0.01% | 813 |
|
|
2025
Q4 | $2.02M | Sell |
140,000
-60,000
| -30% | -$748K | 0.01% | 715 |
|
|
2025
Q3 | $1.93M | Sell |
200,000
-20,000
| -9% | -$177K | 0.01% | 763 |
|
|
2025
Q2 | $1.81M | Sell |
220,000
-75,000
| -25% | -$628K | 0.01% | 826 |
|
|
2025
Q1 | $2.11M | Sell |
295,000
-13,100
| -4% | -$97.4K | 0.01% | 814 |
|
|
2024
Q4 | $2.38M | Buy |
308,100
+93,100
| +43% | +$874K | 0.01% | 632 |
|
|
2024
Q3 | $2.26M | Buy |
215,000
+50,000
| +30% | +$610K | 0.01% | 554 |
|
|
2024
Q2 | $1.93M | Buy |
165,000
+120,100
| +267% | +$1.87M | 0.01% | 534 |
|
|
2024
Q1 | $946K | Sell |
44,900
-45,100
| -50% | -$803K | 0.01% | 543 |
|
|
2023
Q4 | $1.62M | Sell |
90,000
-25,000
| -22% | -$440K | 0.01% | 477 |
|
|
2023
Q3 | $1.89M | Buy |
115,000
+30,000
| +35% | +$544K | 0.01% | 491 |
|
|
2023
Q2 | $1.7M | Buy |
85,000
+24,200
| +40% | +$466K | 0.01% | 526 |
|
|
2023
Q1 | $1.15M | Buy |
60,800
+15,800
| +35% | +$350K | 0.01% | 576 |
|
|
2022
Q4 | $1.02M | Buy |
45,000
+25,000
| +125% | +$565K | 0.01% | 686 |
|
|
2022
Q3 | $529K | Sell |
20,000
-50,000
| -71% | -$1.48M | ﹤0.01% | 890 |
|
|
2022
Q2 | $1.73M | Buy |
70,000
+5,000
| +8% | +$125K | 0.01% | 835 |
|
|
2022
Q1 | $2.16M | Hold |
65,000
| – | – | 0.03% | 679 |
|
|
2021
Q4 | $2.13M | Buy |
65,000
+15,000
| +30% | +$511K | 0.02% | 660 |
|
|
2021
Q3 | $2.1M | Sell |
50,000
-27,500
| -35% | -$990K | 0.03% | 612 |
|
|
2021
Q2 | $3.01M | Buy |
77,500
+31,360
| +68% | +$1.12M | 0.04% | 506 |
|
|
2021
Q1 | $1.57M | Buy |
46,140
+6,140
| +15% | +$262K | 0.02% | 613 |
|
|
2020
Q4 | $1.81M | Sell |
40,000
-223,000
| -85% | -$7.79M | 0.02% | 399 |
|
|
2020
Q3 | $7.24M | Buy |
263,000
+43,000
| +20% | +$1.4M | 0.11% | 166 |
|
|
2020
Q2 | $8.1M | Buy |
220,000
+95,000
| +76% | +$3.54M | 0.14% | 129 |
|
|
2020
Q1 | $4.05M | Sell |
125,000
-15,000
| -11% | -$625K | 0.1% | 183 |
|
|
2019
Q4 | $5.74M | Buy |
140,000
+50,406
| +56% | +$1.99M | 0.13% | 152 |
|
|
2019
Q3 | $3.19M | Buy |
+89,594
| New | +$3.63M | 0.09% | 209 |
|
|
2018
Q3 | – | Sell |
-40,000
| Closed | -$2.87M | – | 870 |
|
|
2018
Q2 | $2.87M | Sell |
40,000
-50,000
| -56% | -$2.39M | 0.04% | 432 |
|
|
2018
Q1 | $2.69M | Buy |
90,000
+15,000
| +20% | +$437K | 0.06% | 382 |
|
|
2017
Q4 | $2.49M | Buy |
75,000
+55,000
| +275% | +$1.66M | 0.05% | 279 |
|
|
2017
Q3 | $659K | Buy |
+20,000
| New | +$450K | 0.02% | 319 |
|
Other funds holding RGNX
RG
Hudson Bay Capital Management's RGNX Position: Q2 2026 in Review
Hudson Bay Capital Management increased its Regenxbio (RGNX) stake by 25% in Q2 2026, buying an estimated $373K and bringing the position to 225,000 shares worth $2.7M. The position accounts for 0.01% of the portfolio, ranked #741.
Hudson Bay Capital Management first reported a position in RGNX in Q3 2017 and has held it in 32 quarters since. The position peaked at $8.1M in Q2 2020. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Hudson Bay Capital Management held 225,000 shares of Regenxbio worth $2.7M as of Q2 2026.
- Hudson Bay Capital Management bought 45,000 Regenxbio shares in Q2 2026, an estimated $373K.
- Regenxbio made up 0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #741 holding.
- Hudson Bay Capital Management first reported a position in Regenxbio in Q3 2017 and has held it in 32 quarters since.
- Hudson Bay Capital Management's Regenxbio position peaked at $8.1M in Q2 2020.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.